These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19641865)

  • 1. Cells therapy for Parkinson's disease--so close and so far away.
    Ren Z; Zhang Y
    Sci China C Life Sci; 2009 Jul; 52(7):610-4. PubMed ID: 19641865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell replacement therapy for Parkinson's disease.
    Wijeyekoon R; Barker RA
    Biochim Biophys Acta; 2009 Jul; 1792(7):688-702. PubMed ID: 19007882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based therapies for Parkinson's disease.
    Dyson SC; Barker RA
    Expert Rev Neurother; 2011 Jun; 11(6):831-44. PubMed ID: 21651331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell replacement therapy for Parkinson's disease using iPS cells].
    Takahashi J
    Rinsho Shinkeigaku; 2013; 53(11):1009-12. PubMed ID: 24291862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
    Staudt MD; Di Sebastiano AR; Xu H; Jog M; Schmid S; Foster P; Hebb MO
    Gerontology; 2016; 62(3):371-80. PubMed ID: 26330171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for a curative cell therapy in Parkinson's disease.
    Laguna Goya R; Tyers P; Barker RA
    J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells and cell replacement therapy for Parkinson's disease.
    Sonntag KC; Simunovic F; Sanchez-Pernaute R
    J Neural Transm Suppl; 2009; (73):287-99. PubMed ID: 20411787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future and current surgical therapies in Parkinson's disease.
    Betchen SA; Kaplitt M
    Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell transplantation for Parkinson's disease.
    Roitberg B; Urbaniak K; Emborg M
    Neurol Res; 2004 Jun; 26(4):355-62. PubMed ID: 15198860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons.
    Kim HJ
    Biochim Biophys Acta; 2011 Jan; 1812(1):1-11. PubMed ID: 20713152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation for stroke.
    Roitberg B
    Neurol Res; 2004 Apr; 26(3):256-64. PubMed ID: 15142317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rewiring the brain with cell transplantation in Parkinson's disease.
    Gaillard A; Jaber M
    Trends Neurosci; 2011 Mar; 34(3):124-33. PubMed ID: 21316770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-cell-based strategies for the treatment of Parkinson's disease.
    Parish CL; Arenas E
    Neurodegener Dis; 2007; 4(4):339-47. PubMed ID: 17627139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.